Renal tubular disease did occur both in all treatment groups, and a unique gene expression signature similar to that elicited by expressing a TCE-associated VHL mutation from renal cell carcinomas was observed specifically in the iAs and TCE combined treatment group. Here, VHL is linked to renal cell carcinoma.